Treatment and prevention of cancer-associated venous thromboembolism

L. Bertoletti (Saint Etienne Cedex, France)

Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Session: Pulmonary embolism: controversies in management
Session type: Respiratory medicine meets other disciplines
Number: 1360

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Bertoletti (Saint Etienne Cedex, France). Treatment and prevention of cancer-associated venous thromboembolism. Virtual Congress 2021 – Pulmonary embolism: controversies in management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prophylaxis of venous thromboembolism : what is new?
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019


Risk of venous thromboembolism in lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 73s
Year: 2004

Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis?
Source: Eur Respir J 2016; 47: 369-373
Year: 2016


Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Efficiency of r-TPA therapy in major venous thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 83s
Year: 2007

Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002

Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Venous thrombo-embolism prophylaxis
Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach
Year: 2009


Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016



Incidental venous thromboembolism, detected by chance, but still venous thromboembolism
Source: Eur Respir J, 55 (2) 2000028; 10.1183/13993003.00028-2020
Year: 2020



The prevalence of hyperhomocysteinemia in venous thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 48s
Year: 2006

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Year: 2018



Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012



Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism
Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018
Year: 2018



Long-term low molecular weight heparin treatment in cancer associated venous thromboembolism patients
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Fever in venous thromboembolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005

Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007

Prospects for the prevention and treatment of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155
Year: 2004